戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 pha-Tocopherol is both an antioxidant and an antiinflammatory agent.
2 irin is the most commonly used analgesic and antiinflammatory agent.
3 ivated protein C, a potent anticoagulant and antiinflammatory agent.
4 se of this nonpsychoactive cannabinoid as an antiinflammatory agent.
5 nts and that these effects were inhibited by antiinflammatory agents.
6  may do so more strongly in combination with antiinflammatory agents.
7 n and for some cancers that are sensitive to antiinflammatory agents.
8 e characterization of novel, mucosal sparing antiinflammatory agents.
9 ions of CpG-ODNs and downstream molecules as antiinflammatory agents.
10       Thus, n-3 PUFAs are potentially potent antiinflammatory agents.
11 y acting muscarinic cholinergic enhancers as antiinflammatory agents.
12 ors, and nitric oxide releasing nonsteroidal antiinflammatory agents.
13 ro and in vivo evidence regarding statins as antiinflammatory agents.
14 e antagonists might be useful as GI specific antiinflammatory agents.
15 stimulus of ICAM-1 up-regulation, are potent antiinflammatory agents.
16 rculosis in humans to evaluate the effect of antiinflammatory agents.
17 s or pain syndromes requiring treatment with antiinflammatory agents.
18 tion and fibrosis, may have potential as new antiinflammatory agents.
19  for the use of selective Hdac inhibitors as antiinflammatory agents.
20 ir action could be useful therapeutically as antiinflammatory agents.
21 5-position were generally quite effective as antiinflammatory agents.
22 hat the 1,2-diarylpyrroles are orally active antiinflammatory agents.
23 bitory properties, may have potential as new antiinflammatory agents.
24  have generated much interest as targets for antiinflammatory agents.
25 yme inhibitors (8 percent), and nonsteroidal antiinflammatory agents (8 percent).
26  An enantioselective synthesis of the potent antiinflammatory agent (-)-acanthoic acid (1) is describ
27                                          The antiinflammatory agent adiponectin was significantly red
28    The conjugate G5-FA-MTX acted as a potent antiinflammatory agent and reduced arthritis-induced par
29 a (Camellia sinensis) polyphenols are potent antiinflammatory agents and have been shown to inhibit N
30 al injury related to the use of nonsteroidal antiinflammatory agents and may be an important alternat
31 continued on a daily regimen of nonsteroidal antiinflammatory agents and prednisone, with a weekly su
32    Our data indicate that TIMP-4 is a potent antiinflammatory agent, and that its antiarthritis funct
33 d significantly less medication (analgesics, antiinflammatory agents, and muscle relaxants) (P< 0.001
34 nclude vasodilators, mesenchymal stem cells, antiinflammatory agents, antiinfection agents, siRNA, an
35                                      Because antiinflammatory agents are already on the market, furth
36 mendations; applications of the nonsteroidal antiinflammatory agents are also discussed.
37 ER-mediated gene expression, but is a potent antiinflammatory agent, as demonstrated in the HLA-B27 t
38 nstrate that SLPI also functions as a potent antiinflammatory agent by interfering with the signal tr
39       Glucocorticoids, immunosuppressive and antiinflammatory agents commonly used in transplantation
40 Leflunomide is a novel immunosuppressive and antiinflammatory agent currently being tested for treatm
41                                          The antiinflammatory agent darbufelone, ((Z)-5-[[3,5-bis(1,1
42  in similar but nonidentical fashions by the antiinflammatory agents dexamethasone and sodium salicyl
43 some inhibitor bortezomib or a commonly used antiinflammatory agent, dexamethasone.
44 iomarker in interventions (particularly with antiinflammatory agents) directed at slowing or halting
45                              The efficacy of antiinflammatory agents during sepsis is dependent on th
46       Glucocorticoids are the most effective antiinflammatory agents for the treatment of chronic inf
47                                     An ideal antiinflammatory agent has not been identified but inhal
48 lthough Helicobacter pylori and nonsteroidal antiinflammatory agents have been identified as key pro-
49          Nitric oxide releasing nonsteroidal antiinflammatory agents have potential usefulness in sub
50 isease, such as probiotics, antibiotics, and antiinflammatory agents, have been suggested as possible
51 ce among bacteria and the adverse effects of antiinflammatory agents highlight the need for alternati
52    Here, we show that vinpocetine acts as an antiinflammatory agent in vitro and in vivo.
53  this relationship prospectively, we studied antiinflammatory agents in models employing differing do
54 nd 62, the nitrates 32 and 61 were effective antiinflammatory agents in the rat air-pouch model.
55 and act as stable, orally available powerful antiinflammatory agents in vivo with doses of 1 mg/kg.
56 ancer development and intake of nonsteroidal antiinflammatory agents, including aspirin.
57  One of the mechanisms by which nonsteroidal antiinflammatory agents inhibit colon carcinogenesis is
58                 HAART used with nonsteroidal antiinflammatory agents leads to the suppression of infl
59 active protein, raising the possibility that antiinflammatory agents may have clinical benefits in pr
60      These data suggest that combinations of antiinflammatory agents may have unanticipated effects o
61 tory effects of other potent and widely used antiinflammatory agents, methotrexate and sulfasalazine,
62    We therefore determined the effect of the antiinflammatory agents montelukast (ML) and fluticasone
63                                 Nonsteroidal antiinflammatory agents (NSAIA) have been shown to exert
64                            Many nonsteroidal antiinflammatory agents (NSAIDs) bind to prostaglandin e
65 ing inflammatory pain is to use nonsteroidal antiinflammatory agents (NSAIDs) that reduce prostanoid
66 comparing aspirin, nonselective nonsteroidal antiinflammatory agents (NSAIDs), and cyclooxygenase (CO
67                   The antagonistic effect of antiinflammatory agents on antidepressant-induced behavi
68 nteraction between antidepressant agents and antiinflammatory agents on antidepressant-induced behavi
69 ur study provides a rationale for the use of antiinflammatory agents or NO-mimetics in the treatment
70 he preclinical and clinical sepsis trials of antiinflammatory agents over the last decade.
71 thritis to date has depended on nonsteroidal antiinflammatory agents such as aspirin.
72 dietary omega-3 fatty acids and nonsteroidal antiinflammatory agents such as Celecoxib suppress colon
73 active metabolite of the di-tert-butylphenol antiinflammatory agent tebufelone.
74 ng animals given placebo or doxycycline plus antiinflammatory agents than among those given doxycycli
75 tudies thus identify vinpocetine as a unique antiinflammatory agent that may be repositioned for the
76 and apoA-I mimetic peptides such as D-4F are antiinflammatory agents that may have therapeutic potent
77 arefully balance the therapeutic benefits of antiinflammatory agents versus the potentially negative
78 transgenic HDL to function as an antioxidant/antiinflammatory agent was associated with a decreased c
79                  Overall, a highly promising antiinflammatory agent was identified.
80  analysis of the clinical trials showed that antiinflammatory agents were also significantly more eff
81 n all the benefits of classical nonsteroidal antiinflammatory agents while avoiding the major side ef
82            Glucocorticoids are commonly used antiinflammatory agents whose use is limited by side eff
83 having therapeutic potential as nonsteroidal antiinflammatory agents with an enhanced gastric safety
84 hosphorylation is a common characteristic of antiinflammatory agents with an ionizable group.
85 e for the combination of peripherally active antiinflammatory agents with drugs that counteract chron
86 X-2) inhibitors have been shown to be potent antiinflammatory agents with fewer side effects than cur
87 6) are particularly interesting as potential antiinflammatory agents with reduced side-effect profile
88                 Therefore, developing unique antiinflammatory agents without significant adverse effe